Literature DB >> 17698630

Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.

Erica L Dahl1, Philip J Rosenthal.   

Abstract

Several classes of antibiotics exert antimalarial activity. The mechanisms of action of antibiotics against malaria parasites have been unclear, and prior studies have led to conflicting results, in part because they studied antibiotics at suprapharmacological concentrations. We examined the antimalarial effects of azithromycin, ciprofloxacin, clindamycin, doxycycline, and rifampin against chloroquine-resistant (W2) and chloroquine-sensitive (3D7) Plasmodium falciparum strains. At clinically relevant concentrations, rifampin killed parasites quickly, preventing them from initiating cell division. In contrast, pharmacological concentrations of azithromycin, ciprofloxacin, clindamycin, and doxycycline were relatively inactive against parasites initially but exerted a delayed death effect, in which the progeny of treated parasites failed to complete erythrocytic development. The drugs that caused delayed death did not alter the distribution of apicoplasts into developing progeny. However, the apicoplasts inherited by the progeny of treated parasites were abnormal. The loss of apicoplast function became apparent as the progeny of antibiotic-treated parasites initiated cell division, with the failure of schizonts to fully mature or for erythrocyte rupture to take place. These findings explain the slow antimalarial action of multiple antibiotics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698630      PMCID: PMC2043295          DOI: 10.1128/AAC.00527-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  47 in total

1.  Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil; a study conducted in 1996 in the French Army.

Authors:  D Baudon; G Martet; B Pascal; J Bernard; A Keundjian; R Laroche
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 May-Jun       Impact factor: 2.184

2.  Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria.

Authors:  Paul N Newton; Jean-François Chaulet; Alan Brockman; Wirongrong Chierakul; Arjen Dondorp; Ronatrai Ruangveerayuth; Sornchai Looareesuwan; Cyril Mounier; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.

Authors:  T N C Ramya; Satyendra Mishra; Krishanpal Karmodiya; Namita Surolia; Avadhesha Surolia
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

4.  A plastid organelle as a drug target in apicomplexan parasites.

Authors:  M E Fichera; D S Roos
Journal:  Nature       Date:  1997-11-27       Impact factor: 49.962

Review 5.  Parasite plastids: approaching the endgame.

Authors:  R J M Iain Wilson
Journal:  Biol Rev Camb Philos Soc       Date:  2005-02

6.  The apicoplast of Plasmodium falciparum is translationally active.

Authors:  Sushma Chaubey; Ambrish Kumar; Divya Singh; Saman Habib
Journal:  Mol Microbiol       Date:  2005-04       Impact factor: 3.501

7.  Effects of antibiotics on Plasmodium falciparum in vitro.

Authors:  T G Geary; J B Jensen
Journal:  Am J Trop Med Hyg       Date:  1983-03       Impact factor: 2.345

8.  Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton.

Authors:  G A McConkey; M J Rogers; T F McCutchan
Journal:  J Biol Chem       Date:  1997-01-24       Impact factor: 5.157

9.  Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum.

Authors:  V Weissig; T S Vetro-Widenhouse; T C Rowe
Journal:  DNA Cell Biol       Date:  1997-12       Impact factor: 3.311

10.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

View more
  131 in total

1.  Characterization of a novel plasmid-borne thiopeptide gene cluster in Staphylococcus epidermidis strain 115.

Authors:  Philip R Bennallack; Scott R Burt; Michael J Heder; Richard A Robison; Joel S Griffitts
Journal:  J Bacteriol       Date:  2014-10-13       Impact factor: 3.490

2.  High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.

Authors:  Jie Xin Tong; Rajesh Chandramohanadas; Kevin Shyong-Wei Tan
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  G-Quadruplex DNA Motifs in the Malaria Parasite Plasmodium falciparum and Their Potential as Novel Antimalarial Drug Targets.

Authors:  Lynne M Harris; Katelyn R Monsell; Florian Noulin; M Toyin Famodimu; Nicolas Smargiasso; Christian Damblon; Paul Horrocks; Catherine J Merrick
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

4.  Toxoplasma gondii myosin F, an essential motor for centrosomes positioning and apicoplast inheritance.

Authors:  Damien Jacot; Wassim Daher; Dominique Soldati-Favre
Journal:  EMBO J       Date:  2013-05-21       Impact factor: 11.598

5.  Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger.

Authors:  Catherine E Oldenburg; Abdou Amza; Boubacar Kadri; Beido Nassirou; Sun Y Cotter; Nicole E Stoller; Sheila K West; Robin L Bailey; Travis C Porco; Jeremy D Keenan; Thomas M Lietman; Bruce D Gaynor
Journal:  Pediatr Infect Dis J       Date:  2018-06       Impact factor: 2.129

6.  Discovery of compounds blocking the proliferation of Toxoplasma gondii and Plasmodium falciparum in a chemical space based on piperidinyl-benzimidazolone analogs.

Authors:  Nadia Saïdani; Cyrille Y Botté; Michael Deligny; Anne-Laure Bonneau; Janette Reader; Ronald Lasselin; Goulven Merer; Alisson Niepceron; Fabien Brossier; Jean-Christophe Cintrat; Bernard Rousseau; Lyn-Marie Birkholtz; Marie-France Cesbron-Delauw; Jean-François Dubremetz; Corinne Mercier; Henri Vial; Roman Lopez; Eric Maréchal
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

7.  Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo.

Authors:  Eva Maria Novoa; Noelia Camacho; Anna Tor; Barrie Wilkinson; Steven Moss; Patricia Marín-García; Isabel G Azcárate; José M Bautista; Adam C Mirando; Christopher S Francklyn; Sònia Varon; Miriam Royo; Alfred Cortés; Lluís Ribas de Pouplana
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

8.  Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum.

Authors:  Ruth Howe; Megan Kelly; John Jimah; Dana Hodge; Audrey R Odom
Journal:  Eukaryot Cell       Date:  2012-12-07

9.  Ketolide agents HMR 3004 and HMR 3647 (telithromycin) inhibit the growth of Plasmodium falciparum in vitro.

Authors:  Marema Makgatho; Eric Maimela; Felix Mbajiorgu
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

10.  Evaluation of the Combination of Azithromycin and Naphthoquine in Animal Malaria Models.

Authors:  Zhu-Chun Bei; Guo-Fu Li; Jing-Hua Zhao; Min Zhang; Xiao-Guang Ji; Jing-Yan Wang
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.